Newly released market study: Argentina Pharmaceuticals & Healthcare Report Q3 2015

Argentina's pharmaceuticals and healthcare sector is expected to experience improved growth rates through the next decade, standing slightly behind growth pattern s in the other l arge markets in Latin America. Combined with expected improvements in the Argentinean business environment to take place with the next government administration since 2016, risks to our pharmaceuticals and healthcare forecasts are weighted to the upside. However, we expect a more mixed market growth picture through the rest of 2015, with expansionary fiscal policy ahead of general elections not able to offset modest consumer confidence . More broadly, lax intellectual property protection will continue to hinder the pharmaceutical market potential while deterring more significant levels of foreign investment.

Headline Expenditure Projections

Pharmaceuticals: ARS49.89bn (USD6.09bn) in 2014 to ARS54.63bn (USD5.67bn) in 2015; +7.3% in local currency terms and -6.9% in US dollar terms. Forecast broadly in line with the previous quarter.

Full Report Details at
- http://www.fastmr.com/prod/991573_argentina_pharmaceuticals.aspx?afid=301

Healthcare: ARS278.35bn (USD33.94bn) in 2014 to ARS304.07bn (USD32.18bn) in 2015; +9.2% in local currency terms and -5.2% in US dollar terms. Forecast broadly in line with the previous quarter.

Risk/Reward Index : In Q3 2015, Argentina's RRI score was revised downwards to 50.9 from 53.3 in the last quarter, remaining above the regional average of 49.7. The score revision was due to lower market growth indices, making Argentina to slide one ranking position to 8 out of 18 markets for the Americas region in BMI's RRI matrix. Argentina's overall score is driven by a large pharmaceutical market (market expenditure score of 14.0 out of 20), significant urbanization leading to better access to healthcare (urban/rural split score of 8.0 out of 8) and an increasing pensionable population (scoring 4.8 out of 8), but dragged down by poor policy enforcement (scoring 1.4 out of 7) and lax intellectual property protection (patent respect score of 2.1...

The Argentina Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Argentina Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Argentina pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Argentina, to test other views - a key input for successful budgeting and strategic business planning in the Argentinian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- South Korea Pharmaceuticals & Healthcare Report Q3 2015
- Central America Pharmaceuticals & Healthcare Report Q3 2015
- Thailand Pharmaceuticals & Healthcare Report Q3 2015
- Nigeria Pharmaceuticals & Healthcare Report Q3 2015
- Mexico Pharmaceuticals & Healthcare Report Q3 2015